Trials / Completed
CompletedNCT01645371
Assessing a Stool Symptom Screener in Patients With Chronic Opioid-Induced Constipation
Assessing the Content Validity of a Stool Symptom Screener in Patients With Chronic Opioid-Induced Constipation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 79 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 84 Years
- Healthy volunteers
- Not accepted
Summary
This qualitative research is to assess the validity of the stool symptom screener that will be used in patients with chronic opioid-induced constipation to determine the adequacy of their response to laxatives.
Detailed description
Assessing the Content Validity of a Stool Symptom Screener in Patients with Chronic Opioid-Induced Constipation
Conditions
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2012-07-20
- Last updated
- 2014-10-20
Source: ClinicalTrials.gov record NCT01645371. Inclusion in this directory is not an endorsement.